C6orf47_D17H6S53E Inhibitors
C6orf47, also known as D17H6S53E, denotes a protein encoded by a specific gene found within the human genome. This protein is a part of a complex network of molecular interactions and pathways within cells, playing a critical role in cellular functions and processes. The exact function of C6orf47 remains an area of active research, with scientists exploring its involvement in various cellular mechanisms. As with many proteins, understanding the precise role and activity of C6orf47 is crucial for elucidating its contribution to the cellular environment, including how it interacts with other proteins, its role in signaling pathways, and its impact on cell behavior.
Inhibitors of C6orf47, or D17H6S53E inhibitors, represent a class of chemicals designed to specifically bind to and inhibit the activity of the C6orf47 protein. These inhibitors are often small molecules that can interact with the protein's active site or other critical regions, thereby modulating its activity. The development and study of such inhibitors are driven by the goal of understanding the protein's function and its involvement in cellular processes more deeply. By inhibiting C6orf47, researchers can observe the resulting effects on cells, which in turn provides insights into the protein's role and importance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis by blocking the translational step, thus can inhibit the synthesis of C6orf47. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor which prevents protein degradation. If C6orf47 undergoes proteasomal degradation, MG132 can stabilize its expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methylation inhibitor. If C6orf47 expression is regulated by methylation, this can alter its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA synthesis. By doing so, it can reduce the transcription of many genes, possibly including C6orf47. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. If C6orf47 is involved in or affected by the PI3K-Akt pathway, this compound can modulate its function or expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that dampens the MAPK/ERK pathway. If C6orf47 function intersects with this pathway, its function can be modulated by this inhibitor. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Protein kinase inhibitor. If C6orf47 has kinase activity or is modulated by kinases, its function can be affected by Staurosporine. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor. It can influence C6orf47 if it's associated with the PI3K-Akt signaling pathway. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpain inhibitor. If C6orf47 is processed or modulated by calpains, Calpeptin can affect its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. If C6orf47's function or expression is regulated by p38 MAPK, then this chemical can potentially modulate its activity. | ||||||